Antag Therapeutics Revenue and Competitors

Location

$93M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Antag Therapeutics's estimated annual revenue is currently $3.6M per year.(i)
  • Antag Therapeutics's estimated revenue per employee is $155,000
  • Antag Therapeutics's total funding is $93M.

Employee Data

  • Antag Therapeutics has 23 Employees.(i)
  • Antag Therapeutics grew their employee count by 15% last year.

Antag Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Antag Therapeutics?

Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professors Mette M. Rosenkilde and Jens J. Holst have discovered naturally occurring therapeutic peptides that are being investigated in several human studies.

keywords:N/A

$93M

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M23-18%N/A
#2
$2.8M235%$17.1M
#3
$1.6M23-15%$6.8M
#4
$2.3M2310%N/A
#5
$2.3M23N/AN/A